Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer

J Clin Oncol. 2008 Feb 20;26(6):1006-8. doi: 10.1200/JCO.2007.14.7231.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / metabolism
  • Adenocarcinoma / secondary*
  • Adult
  • Antimetabolites, Antineoplastic / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Biomarkers, Tumor / metabolism
  • Capecitabine
  • Cisplatin / adverse effects
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives
  • Fluorouracil / adverse effects
  • Fluorouracil / analogs & derivatives
  • Hepatomegaly / etiology
  • Hepatomegaly / therapy
  • Humans
  • Immunohistochemistry
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Male
  • Risk Factors
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / pathology*
  • Tomography, X-Ray Computed
  • Tumor Lysis Syndrome / etiology*
  • Tumor Lysis Syndrome / metabolism
  • Tumor Lysis Syndrome / prevention & control
  • Tumor Lysis Syndrome / therapy*

Substances

  • Antimetabolites, Antineoplastic
  • Biomarkers, Tumor
  • Deoxycytidine
  • Capecitabine
  • Cisplatin
  • Fluorouracil